2011
DOI: 10.1007/978-94-007-1217-1_2
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms Regulating Airway Nucleotides

Abstract: In the respiratory system, extracellular nucleotides and nucleosides serve as signaling molecules for a wide spectrum of biological functions regulating airway defenses against infection and toxic material. Their concentrations are controlled by a complex network of cell surface enzymes named ectonucleotidases. This highly integrated metabolic network combines the activities of three dephosphorylating ectonucleotidases, namely nucleoside triphosphate diphosphohydrolases (NTPDases), nucleotide pyrophosphatase/p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(12 citation statements)
references
References 187 publications
0
12
0
Order By: Relevance
“…In the in vitro experiments, however, the catabolism sensitive to ARL-67156 appears to be insignificant because this drug failed to potentiate the OVA-induced contraction, despite the fact that the contraction was partially mediated by nucleotides release (as suramin plus RB2 caused rightward displacement of the concentration-response curve to OVA). It is reasonable to speculate that in airways, the catabolism of these compounds is locally carried out by ARL-67156-insensitive ectonucleotidases such as NPP2, NPP3, TNAP, and PLAP (8,41), which have been detected in airway epithelium and lung parenchyma (42)(43)(44)(45). Moreover, we were able to demonstrate that sensitization procedure dramatically increased the alkaline phosphatase activity in airway epithelium, thus providing a more powerful system to metabolize ATP and other nucleotides.…”
Section: Discussionmentioning
confidence: 87%
“…In the in vitro experiments, however, the catabolism sensitive to ARL-67156 appears to be insignificant because this drug failed to potentiate the OVA-induced contraction, despite the fact that the contraction was partially mediated by nucleotides release (as suramin plus RB2 caused rightward displacement of the concentration-response curve to OVA). It is reasonable to speculate that in airways, the catabolism of these compounds is locally carried out by ARL-67156-insensitive ectonucleotidases such as NPP2, NPP3, TNAP, and PLAP (8,41), which have been detected in airway epithelium and lung parenchyma (42)(43)(44)(45). Moreover, we were able to demonstrate that sensitization procedure dramatically increased the alkaline phosphatase activity in airway epithelium, thus providing a more powerful system to metabolize ATP and other nucleotides.…”
Section: Discussionmentioning
confidence: 87%
“…Under the nutrient-rich conditions provided by the CF airway milieu (9,11,12,14), environmental strains of autotrophic bacteria acquired by patients overcome the many negative aspects of this hypoxic and antimicrobial-, protease-, and oxidant-laden environment to thrive and undergo auxotrophic adaptation over time (10). Hence, the CF airway milieu exerts significant selective pressure on incoming bacteria, in large part through metabolic routes.…”
Section: Discussionmentioning
confidence: 99%
“…Both glucose (9) and amino acids (10) tend to accumulate in CF airway fluid as the result of an apparent failure of the epithelium, lacking functional CFTR protein, to transport these anabolic nutrients (11)(12)(13). Additionally, CF airway fluid is enriched in breakdown products of phosphonucleotides (14), which fuel cellular energy production. To investigate the process of metabolic adaptation by neutrophils recruited to CF airways, we used novel retroviral envelope glycoprotein (Env)-derived ligands (15,16) combined with multicolor flow cytometry to characterize the expression of glucose/ dehydroascorbic acid (Glut1), neutral amino acid (ASCT2), and inorganic phosphate (PiT1 and PiT2) transporters on CF blood and airway neutrophils.…”
mentioning
confidence: 99%
“…CD39/NTPDase1/ecto-apyrase is the dominant purinergic ecto-enzyme in the immune and vascular barrier in the lung, and it is also a key regulator of the functionality of immune cells [8]. It regulates ATP-mediated P2 receptor signalling by hydrolysing ATP/ ADP to AMP, which is then further metabolised by CD73/ecto-5′-nucleotidase to adenosine [9].…”
Section: Introductionmentioning
confidence: 99%